Aptorum Group Share Price Today
(NASDAQ: APM)

Name: Aptorum Group Share Price Today (NASDAQ: APM) - Aptorum Group Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Aptorum Group share price is $0.98 & ₹85.23 as on 6 Mar 2025, 2.30 'hrs' IST

$0.98

▲

0.07

(7.79%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Aptorum Group share price in Dollar and Rupees. Guide to invest in Aptorum Group stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Aptorum Group, along with analyst recommendations, forecasts, and comprehensive financials.

Aptorum Group share price movements

Today's Low: $0.93
Today's High: $0.99
$0.98
5.1%
Downside
Day's Volatility :6.06%
Upside
1.01%
52 Weeks Low: $0.46
52 Weeks High: $17.49
$0.98
53.06%
Downside
52 Weeks Volatility :97.37%
Upside
94.4%

Aptorum Group (APM) Returns

Period	Aptorum Group Ltd	Index (Russel 2000)
3 Months	21.96%	0.0%
6 Months	-69.69%	0.0%
1 Year	-90.42%	0.0%
3 Years	-92.95%	-11.6%

Aptorum Group (APM) Key Statistics

in dollars & INR

Previous Close	$0.909184
Open	$0.91
Today's High	$0.99
Today's Low	$0.93
Market Capitalization	$6.5M
Today's Volume	$810.0
52 Week High	$17.49
52 Week Low	$0.46
Revenue TTM	$0.0
EBITDA	$-6.3M
Earnings Per Share (EPS)	$0.3
PE Ratio	2.97
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-3.04%

How to invest in Aptorum Group Stock (APM) from India?

It is very easy for Indian residents to invest directly in Aptorum Group from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Aptorum Group stock in both Indian Rupees (INR) and US Dollars (USD). Search for Aptorum Group or APM on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Aptorum Group or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Aptorum Group shares which would translate to 0.887 fractional shares of Aptorum Group as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Aptorum Group, in just a few clicks!

Returns in Aptorum Group (APM) for Indian investors in Rupees

The Aptorum Group stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Aptorum Group investment value today

Current value as on today

₹15,289

Returns

₹84,711

(-84.71%)

Returns from Aptorum Group Stock

₹89,673 (-89.67%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Aptorum Group (APM)

-83%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Aptorum Group Stock from India on INDmoney has decreased by -83% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Aptorum Group

Geode Capital Management, LLC
0.54%
Morgan Stanley - Brokerage Accounts
0.13%

Analyst Recommendation on Aptorum Group

Buy

83%Buy

16%Hold

0%Sell

Based on 6 Wall street analysts offering stock ratings for Aptorum Group(by analysts ranked 0 to 5 stars)

Based on 6 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Aptorum Group Stock (APM)

What analysts predicted

Upside of 8063.27%

Target:

$80.00

Current:

$0.98

Insights on Aptorum Group Stock (Ticker Symbol: APM)

Price Movement
In the last 3 months, APM stock has moved up by 22.0%
APM vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 99.6%
APM vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 47.7% return, outperforming this stock by 140.6%

APM Aptorum Group Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$383.5K	-
Net Income	$-14.8M	↑ 482.22%
Net Profit Margin	-3.9K%	-

	FY19	Y/Y Change
Revenue	$535.2K	↑ 39.57%
Net Income	$-20.9M	↑ 40.61%
Net Profit Margin	-3.9K%	↓ 28.87%

	FY20	Y/Y Change
Revenue	$911.5K	↑ 70.32%
Net Income	$7.1M	↓ 133.89%
Net Profit Margin	775.29%	↑ 4672.13%

	FY21	Y/Y Change
Revenue	$1.5M	↑ 69.15%
Net Income	$-25.3M	↓ 457.84%
Net Profit Margin	-1.6K%	↓ 2415.5%

	FY22	Y/Y Change
Revenue	$1.3M	↓ 15.95%
Net Income	$-5.3M	↓ 78.98%
Net Profit Margin	-410.1%	↑ 1230.11%

	FY23	Y/Y Change
Revenue	$431.4K	↓ 66.71%
Net Income	$-2.8M	↓ 46.85%
Net Profit Margin	-654.8%	↓ 244.7%

	Q1 FY22	Q/Q Change
Revenue	$-1.3M	-
Net Income	$-2.2M	-
Net Profit Margin	177.14%	-

	Q2 FY22	Q/Q Change
Revenue	$527.5K	↓ 142.03%
Net Income	$-1.9M	↓ 15.19%
Net Profit Margin	-357.42%	↓ 534.56%

	Q1 FY23	Q/Q Change
Revenue	$768.4K	↑ 45.68%
Net Income	$-7.9M	↑ 319.8%
Net Profit Margin	-1.0K%	↓ 672.52%

	Q3 FY23	Q/Q Change
Revenue	$431.4K	↓ 43.86%
Net Income	$-5.5M	↓ 30.67%
Net Profit Margin	-1.3K%	↓ 242.05%

	FY18	Y/Y Change
Profit	$65.4K	-

	FY19	Y/Y Change
Profit	$-259.4K	↓ 496.37%

	FY20	Y/Y Change
Profit	$-103.5K	↓ 60.09%

	FY21	Y/Y Change
Profit	$81.9K	↓ 179.08%

	FY22	Y/Y Change
Profit	$80.1K	↓ 2.19%

	FY23	Y/Y Change
Profit	$10.6K	↓ 86.8%

	Q1 FY22	Q/Q Change
Profit	$-2.5M	-

	Q2 FY22	Q/Q Change
Profit	$-585.2K	↓ 76.46%

	Q1 FY23	Q/Q Change
Profit	$-542.2K	↓ 7.35%

	Q3 FY23	Q/Q Change
Profit	$-665.3K	↑ 22.71%

	Q1 FY24	Q/Q Change
Profit	$-454.6K	↓ 31.67%

	FY18	Y/Y Change
Operating Cash Flow	$-10.0M	↑ 73.54%
Investing Cash Flow	$-6.1M	↓ 147.35%
Financing Cash Flow	$25.5M	↑ 180.54%

	FY19	Y/Y Change
Operating Cash Flow	$-13.4M	↑ 33.35%
Investing Cash Flow	$-108.1K	↓ 98.22%
Financing Cash Flow	$-7.3M	↓ 128.74%

	FY20	Y/Y Change
Operating Cash Flow	$-15.9M	↑ 19.05%
Investing Cash Flow	$1.8M	↓ 1804.74%
Financing Cash Flow	$12.4M	↓ 269.62%

	FY21	Y/Y Change
Operating Cash Flow	$-14.7M	↓ 8.04%
Investing Cash Flow	$16.5M	↑ 796.07%
Financing Cash Flow	$2.8M	↓ 77.61%

	Q1 FY22	Q/Q Change
Operating Cash Flow	$3.3B	↑ 0.0%
Investing Cash Flow	$1.4M	↑ 0.0%
Financing Cash Flow	$32.8B	↑ 0.0%

	Q2 FY22	Q/Q Change
Operating Cash Flow	$-6.8M	↓ 100.2%
Investing Cash Flow	$1.4M	↑ 0.0%
Financing Cash Flow	$3.0M	↓ 99.99%

Aptorum Group Technicals Summary

Sell

Neutral

Buy

Aptorum Group is currently in a neutral trading position according to technical analysis indicators.

Aptorum Group (APM) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Aptorum Group Ltd	-20.94%	-69.69%	-90.42%	-92.95%	-97.38%
Regeneron Pharmaceuticals, Inc.	1.3%	-41.29%	-30.51%	9.2%	42.38%
Beone Medicines Ltd	15.19%	34.31%	61.3%	43.16%	68.1%
Vertex Pharmaceuticals Incorporated	3.37%	3.77%	18.06%	106.43%	121.36%
Alnylam Pharmaceuticals, Inc.	-11.52%	-3.4%	62.32%	49.04%	120.93%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Aptorum Group Ltd	2.97	2.97	NA	0.0	-0.03	-0.27	NA	4.14
Regeneron Pharmaceuticals, Inc.	17.85	17.85	1.03	43.09	0.16	0.07	0.01	273.57
Beone Medicines Ltd	NA	NA	NA	1.43	-0.19	-0.06	NA	31.22
Vertex Pharmaceuticals Incorporated	32.84	NA	1.33	18.07	-0.03	0.13	NA	63.87
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	0.57	-15.01	-0.03	NA	0.52

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Aptorum Group Ltd	Buy	$6.5M	-97.38%	2.97	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$74.9B	42.38%	17.85	31.07%
Beone Medicines Ltd	NA	$28.5B	68.1%	NA	-16.92%
Vertex Pharmaceuticals Incorporated	Buy	$124.1B	121.36%	32.84	-4.86%
Alnylam Pharmaceuticals, Inc.	Buy	$31.5B	120.93%	NA	-12.37%

About Aptorum Group

Aptorum Group Limited, through its subsidiaries, operates as a clinical stage biopharmaceutical company that engages in the discovery, development, and commercialization of therapeutic products for the treatment of oncology and infectious diseases. The company operates in the Therapeutics and Non-Therapeutics segments. Its pipeline products include SACT- 1 for neuroblastoma and other cancer types; SACT-COV19 for the treatment of coronavirus disease; ALS-4 to treat bacterial infections caused by staphylococcus aureus, including MRSA; ALS-1 to treat viral infections caused by influenza virus A; and ALS-2/3 for the treatment of gram+ve bacterial infections. The company is also developing RPIDD, a pathogen molecular diagnostic; NativusWell DOI (NLS-2), a dietary supplement; NLS-1 for the treatment of endometriosis; DLS-1+2 to treat NSCLC with mutation; DLS-3, an autoimmune small molecule; and CLS-1 for the treatment of obesity. Its pipeline products enable the discovery of new therapeutics assets, such as systematic screening of existing approved drug molecules, and microbiome-based research platforms for treatment of metabolic diseases. The company also focuses on therapeutic and diagnostic projects in neurology, gastroenterology, metabolic disorders, and other disease areas. In addition, it is involved in the operation of medical clinics. The company was formerly known as APTUS Holdings Limited and changed its name to Aptorum Group Limited in October 2017. Aptorum Group Limited was incorporated in 2010 and is headquartered in London, the United Kingdom.

Organization	Aptorum Group
Employees	3
CEO	Mr. Chung Yuen Huen
Industry	Health Technology

Management People of Aptorum Group

Name	Title
Mr. Chung Yuen Huen	Founder, CEO & Non-Executive Director
Mr. Kwok Kuen Wong	Head of Finance

Important FAQs about investing in APM Stock from India :

What is Aptorum Group share price today?

Aptorum Group share price today stands at $0.98, Open: $0.91 ; Previous Close: $0.91 ; High: $0.99 ; Low: $0.93 ; 52 Week High: $17.49 ; 52 Week Low: $0.46.

The stock opens at $0.91, after a previous close of $0.91. The stock reached a daily high of $0.99 and a low of $0.93, with a 52-week high of $17.49 and a 52-week low of $0.46.

Can Indians buy Aptorum Group shares?

Yes, Indians can invest in the Aptorum Group (APM) from India.

With INDmoney, you can buy Aptorum Group at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Aptorum Group at zero transaction cost.

How can I buy Aptorum Group shares from India?

It is very easy to buy Aptorum Group from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Aptorum Group (APM) be purchased?

Yes, you can buy fractional shares of Aptorum Group with INDmoney app.

What are the documents required to start investing in Aptorum Group stocks?

To start investing in Aptorum Group, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.